Essential Amino Acid Supplementation in Older Adult COVID-19 Patients
Status:
Withdrawn
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
A 4-week treatment of essential amino acids or placebo to participants with: 1) negative
COVID-19 test with exposure, or 2) positive COVID-19 test and no or mild symptoms. The study
team will measure change in symptoms. Participants will complete symptom surveys for 4 weeks
and once at 8 and 12 weeks as well as pre- and post-assessments.